Alterola Biotech, Inc. (ABTI)
- Previous Close
0.0033 - Open
0.0199 - Bid --
- Ask --
- Day's Range
0.0199 - 0.0199 - 52 Week Range
0.0012 - 0.0200 - Volume
400 - Avg. Volume
2,483 - Market Cap (intraday)
27.515M - Beta (5Y Monthly) -0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Jun 1, 2024 - Jun 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. was founded in 2021 and is based in Birkenhead, the United Kingdom.
www.alterolabio.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ABTI
Performance Overview: ABTI
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ABTI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ABTI
Valuation Measures
Market Cap
27.51M
Enterprise Value
27.76M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-3.36
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-17.38%
Return on Equity (ttm)
-64.97%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.88M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
2.57k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-236.1k